FRM
Fox Run Management’s Ionis Pharmaceuticals IONS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $434K | Buy |
+10,988
| New | +$434K | 0.07% | 522 |
|
|
2024
Q3 | – | Sell |
-5,421
| Closed | -$258K | – | 944 |
|
|
2024
Q2 | $258K | Buy |
+5,421
| New | +$258K | 0.05% | 593 |
|
|
2024
Q1 | – | Sell |
-9,271
| Closed | -$469K | – | 922 |
|
|
2023
Q4 | $469K | Buy |
+9,271
| New | +$469K | 0.12% | 331 |
|
|
2022
Q3 | – | Sell |
-15,947
| Closed | -$590K | – | 718 |
|
|
2022
Q2 | $590K | Buy |
15,947
+6,893
| +76% | +$255K | 0.29% | 84 |
|
|
2022
Q1 | $335K | Buy |
9,054
+1,730
| +24% | +$64K | 0.19% | 230 |
|
|
2021
Q4 | $223K | Sell |
7,324
-17
| -0.2% | -$518 | 0.13% | 331 |
|
|
2021
Q3 | $246K | Buy |
+7,341
| New | +$246K | 0.15% | 299 |
|
|
2018
Q1 | – | Sell |
-8,250
| Closed | -$415K | – | 809 |
|
|
2017
Q4 | $415K | Buy |
8,250
+2,450
| +42% | +$123K | 0.12% | 349 |
|
|
2017
Q3 | $294K | Buy |
+5,800
| New | +$294K | 0.08% | 502 |
|